1. 2023
  2. Treatment of COVID‐19 patients with a SARS‐CoV‐2‐specific siRNA‐peptide dendrimer formulation

    Khaitov, M., Nikonova, A., Kofiadi, I., Shilovskiy, I., Smirnov, V., Elisytina, O., Maerle, A., Shatilov, A., Shatilova, A., Andreev, S., Sergeev, I., Trofimov, D., Latysheva, T., Ilyna, N., Martynov, A., Rabdano, S., Ruzanova, E., Savelev, N., Pletiukhina, I., Safi, A. & 18 others, Ratnikov, V., Gorelov, V., Kaschenko, V., Kucherenko, N., Umarova, I., Moskaleva, S., Fabrichnikov, S., Zuev, O., Pavlov, N., Kruchko, D., Berzin, I., Goryachev, D., Merkulov, V., Shipulin, G., Udin, S., Trukhin, V., Valenta, R. & Skvortsova, V., 14 Feb 2023, In: Allergy: European Journal of Allergy and Clinical Immunology. 78, 6, p. 1639-1653

    Research output: Contribution to journalArticlepeer-review

ID: 38281387